• 01

    September

    Mexico first country to launch Ryzodeg® ... Read more

    27

    August

    Novo Nordisk buys production plant in New Hampshire ... Read more

    22

    August

    Copenhagen joins ‘Cities Changing Diabetes’ ... Read more

    18

    August

    Novo Nordisk accepts fine for violating disclosure obligation in Denmark ... Read more

  • 01

    September

    Share repurchase programme ... Read more

    25

    August

    Share repurchase programme ... Read more

    18

    August

    Share repurchase programme ... Read more

    08

    August

    Trading in Novo Nordisk shares by board members, executives and associated perso ... Read more

  • 8

    September

    Handelsbanken Nordic Large Cap Seminar, Stockholm

    10

    September

    Morgan Stanley Global Healthcare Conference, New York

    15

    September

    EASD, Vienna

    19

    September

    Kepler Cheuvreux Conference, Paris

Stock quotes

259.30 +0.12

Advanced view

Key events


EASD 2014 in Vienna

On 17 September 2014 Novo Nordisk will host an investor and analyst event in connection with the European Association for the Study of Diabetes (EASD) annual meeting.

The event will be hosted by Chief Financial Officer Jesper Brandgaard and Chief Science Officer Mads Krogsgaard Thomsen.
Presentations and a Q&A session will be transmitted via webcast from 17:30–19:30 CET, 17 September.

Link to the conference call webcast will is available 
here

The presentation will also be available in the Download Centre.

Latest uploads

Conference calls
Investor presentation from London
Shareholder magazine
Share Q2 2014
Interim reports
First six months of 2014 financial statement
IR presentations
First six months of 2014
General Meetings
Annual General Meeting

Related links

Printed reports and other publications
Order  

Dividend and stock split information
See

Investor package for the second quarter of 2014
Earnings conference call
Roadshow presentation
Company Announcement
Downloadable financial data